Quality metrics
| Perioperative course | Quality metric (%) | Target | Measure type |
| Procedure specific | Haemodialysis access fistulas versus graft | >60% | Process |
| In-hospital postoperative | Stroke | <3% | Outcome |
| Coronary catheterisation | <5% | Outcome | |
| With two troponin levels>0.100 μg/L within 7 days of surgery | <5% | Outcome | |
| Unplanned operation or angio intervention after index procedure | <15% | Outcome | |
| Death | <0.05% | Outcome | |
| At discharge | Length of stay | – | Outcome |
| Statin order at discharge | >80% | Process | |
| Antiplatelet or anticoagulant at discharge | >95% | Process | |
| With anaemia (haemoglobin<80 g/L) within 48 hours of discharge | <5% | Outcome | |
| With two serum glucose levels>10.0 mmol/L within 48 hours of discharge | <5% | Outcome | |
| Intermediate and long-term postoperative | Incisional dehiscence or hernia within 90 days | <5% | Outcome |
| Surgical site infection within 90 days | <10% | Outcome | |
| Repeat intervention within 90 days | <15% | Outcome | |
| Repeat haemodialysis access surgery within 1 year | <20% | Outcome | |
| Follow-up imaging surveillance | With ≥3 imaging follow-up tests within 13 months of EVAR | >90% | Process |
| With ≥3 duplex studies within 13 months of PAD bypass with vein | >90% | Process |
EVAR, Endovascular Abdominal Aortic Aneurym Repair; PAD, Peripheral Artery Disease.